Accelerated stability study of the ester prodrug remdesivir: Recently FDA‐approved Covid‐19 antiviral using reversed‐phase‐HPLC with fluorimetric and diode array detection
- 5 July 2021
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 35 (12) , e5212
Abstract
Remdesivir (RDV) is the first antiviral drug, approved by the Food and Drug Administration, to treat severe acute respiratory syndrome coronavirus 2. RDV is a relatively new chemical entity, ‘ester prodrug’, with no reported stability profile. Due to the urgency of its use and thus fast production, it is important to develop a stability‐indicating method for its assay. Chromatographic separation was carried out on a C18 column (250 × 4.6 mm, 5 µm) with dual detection: diode array at 240 nm and fluorescence at λex/em 245/390 nm. Isocratic elution of acetonitrile and distilled water (acidified with phosphoric acid, pH 4) in the ratio of 55:45 (v/v), respectively, was used. The linearity range using HPLC‐diode array detection was 0.1–15 μg/mL, whereas that using fluorimetric detection was 0.05–15 μg/mL. As per the International Conference on Harmonization guidelines, RDV has been degraded by accelerated alkaline, acidic, neutral hydrolysis, oxidative, heat, and photolytic stress conditions. Possible degradation hypothesis of the parent molecule has been suggested and illustrated. The proposed methods have achieved selective determination of the intact drug with no peaks overlapping in all assumptions. Extensive degradation confirms threatened drug stability at thermal and basic hydrolytic stressing. The developed methods were fully validated and proved suitable for quality control routine analysis of RDV in raw material and pharmaceutical dosage forms.Keywords
This publication has 14 references indexed in Scilit:
- Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC–MS/MS method in human serumJournal of Pharmaceutical and Biomedical Analysis, 2021
- Remdesivir against COVID-19 and Other Viral DiseasesClinical Microbiology Reviews, 2020
- Remdesivir for COVID-19: A review of pharmacology, mechanism of action, in-vitro activity and clinical use based on available case studiesJournal of Drug Delivery and Therapeutics, 2020
- A stability-indicating UPLC method for the determination of curcumin diethyl disuccinate, an ester prodrug of curcumin, in raw materialsHeliyon, 2020
- Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy SubjectsClinical and Translational Science, 2020
- Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patientClinical Chemistry and Laboratory Medicine (CCLM), 2020
- Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus diseaseJournal of Antimicrobial Chemotherapy, 2020
- Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug productTalanta, 2015
- Practical and regulatory considerations for stability-indicating methods for the assay of bulk drugs and drug formulationsTrAC Trends in Analytical Chemistry, 2013
- Thermal stability and decomposition of pharmaceutical compoundsJournal of Thermal Analysis and Calorimetry, 2007